Navigation Links
Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
Date:1/7/2009

BETHESDA, Md., Jan. 7 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR) announced today that it plans to report its results of operations for the year ended December 31, 2008, on Tuesday, February 10, 2009.

The Company plans to issue a press release announcing the results for the year ended December 31, 2008 on Tuesday, February 10, 2008, after the close of the market. The conference call is scheduled to begin at 9:00 a.m., EST, on Wednesday, February 11, 2008. Those wishing to participate should call 1-800-374-1855. In addition, a replay will be available until February 18, 2009, by dialing 1-800-642-1687 and referencing Conf. ID #76986159.

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 677 patient care centers in 45 states and the District of Columbia, with over 3,500 employees including 1,080 practitioners (as of September 30, 2008). Hanger is organized into four units. The two key operating units are patient care which consists of nationwide orthotic and prosthetic practice centers and distribution which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide(R), visit http://www.ininc.us. For more information on Hanger, vis
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
2. Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)
3. Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call
5. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
6. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
7. Hanger Orthopedic Group, Inc. Announces Second Quarter 2008 Earnings Release Conference Call
8. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Standard & Poors Rating Services
9. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
10. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
11. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... HOUSTON - Using routine computed tomography (CT) ...colorectal liver metastasis after bevacizumab and ...ng to research from The University of Texas M. D. ...shed in the Dec. 2 issue of JAMA . , When combi...bevacizumab, also known as Avastin, is associated ...
(Date:12/1/2009)..., , MEXICO CITY, Dec. 1 Th...l build a world-class center for biomedical and na...The center for medical research and development wi...ersity of Mexico, the top Spanish speaking univers... to begin construction in 2010, has been designed ...
(Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca...
(Date:12/1/2009)... PHILADELPHIA (December 1, 2009) Wistar Institut...y of Pennsylvania and New York University have ide...ndicate early-stage lung tumors in people at high ...lished online December 1 in Cancer Research , a j...arch, could lead to a simple blood test to detect ...
(Date:12/1/2009)..., , SMITHFIELD, R.I., Dec....ctive equipment, bad assumptions are hazardous and... years of government regulation, a handful of pers...ng both the effectiveness of occupational Hearing...ng. ,, A new free, white paper from Howard Lei...
Breaking Medicine News(10 mins):Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 3Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3
...und derived from the cottonseed oil had showed pro... Scientist from University of Michigan Compreh...ompound called gossypol regulates the protein call...they are resistant to chemotherapy. Surgeries on s...
...y that came out in the journal Environmental Healt...ffects of clear plastics on human beings. Bi...lastics that are used as food grade materials for ...nd out about the long-term exposure to BPA. T...
...who are at a high risk of having fractures, are of...l// calcium as a preventive measure. Recent study ... true. Calcium and vitamin D may not be successful...fore they had a low trauma fracture. These people ...
...from Sweden had been able to cure people suffering... The researchers believe that hypnosis may be a ...tients of an average age of 34 yrs with moderate t...dom parallel group was used as control for the stu...
...rm pregnancy at the age of 20yrs may be the protec...s from Fox Chase Cancer Center in Philadelphia sai...only after a full term pregnancy. Once the cells a... research study had successfully shown that pregna...
...the problem of asthma, it may help if they take co...ake anti-inflammatory medication regularly. P...he symptoms of an attack had the same rate of seve... Asthma is considered mild when the symptoms exi...
Other Medicine News:
(Date:12/1/2009)... 1 MedNet Solutions, a global life...g in clinical study management systems, today anno... EDC/eClinical technology solution, has been certi...nsortium (CDISC) as complying with the Operational...derscores MedNet,s commitment to streamlining the ...
(Date:12/1/2009)...APOLIS, Dec. 1 The educa... Health... Improving Life," created by Lilly USA (...tterhealth.com/value_of_medicine.jsp . The booklet... That Matter" and encourages an open dialogue with...pharmaceutical industry practices. ,, "Today, ...
(Date:12/1/2009)... 1 SCOLR Pharma, Inc. (N...09 it licensed to Chrono Nutraceuticals LLC exclus...extended release dietary supplements using SCOLR,s... addition, SCOLR granted Chrono rights to manufact...ates on a nonexclusive basis. Chrono paid SCOLR $...
Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 1QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 2QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 3QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting 5008 4InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 1InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 2Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 1Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 2Community Mitigation Lessons From Mexicos A 28H1N1 29 Response 57286 3
...vices,International Inc. (Pink Sheets: MSITF) is p...engue Fever Kit is increasing. Dengue Fever is,spr...ne of the worst,outbreaks in decades causing agoni...e and killing 200 people so far this year. This y... Americas and,with the upcoming rainy season, case...
...itial focus on oncology: most, actively research...ed reagent performance and enhanced pr...ostics,Inc. (Nasdaq: SDIX ) -- today announced th...dy reagents in support of oncology-based research ...l been manufactured utilizing,SDI,s proprietary Ge...
Other Medicine Technology:Demand for VScan Dengue Fever Test Kits Increases 2Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 2Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 3Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 4Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 5
Reliavac® 400ccEvacuators & Kits
Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing
Bile Bags
Whelan-Moss T-Tube
Medicine Products: